
MeRes100 · Coronary Stents
MeRes100 BRS Sirolimus-Eluting Bioresorbable Vascular Scaffold
| Technical Blueprint Specification | Clinical Value |
|---|---|
Scaffold Strut Thickness | 100 μm |
Scaffold Diameters | 2.50, 2.75, 3.00, 3.25, 3.50, 4.00, 4.50 mm |
Scaffold Lengths | 13, 16, 19, 24, 29, 32, 37, 40 mm |
Tri-axial RO Markers | Platinum (Couplets of tri-axial RO markers at either end, 120° apart from each other) |
Equivalent Drug Dose | 1.25 µg/mm² |
Nominal Pressure (NP) | 9 atm |
Rated Burst Pressure (RBP) | 16 atm |
Balloon Overhang | < 0.5 mm |
Shaft Outer Diameter | Proximal 1.95 F / Distal 2.7 F |
Radiopaque Markers | 2 - Platinum / Iridium |
Usable Catheter Length | 140 cm |
Guide Catheter Compatibility | 6 F (Min. I D 0.070" / 1.8 mm) |
Max. Guidewire | 0.014" (0.36 mm) |
Scaffold Material
BioResorbable PLLA (Poly L-lactide)
Drug
Sirolimus
Polymer
BioResorbable PDLLA (Poly D, L-lactide)
Delivery System
Rapid Exchange
Primary Material
PLLA (Poly L-lactide)
Clinical Sizing Precision
100 μm strut thickness, PLLA scaffold with PDLLA drug coating, platinum markers
This product is manufactured by Meril Life Sciences and is distributed by Agile Healthcare across all districts of Telangana.
Yes, all Meril Life Sciences products distributed by Agile Healthcare, including the MeRes100 BRS Sirolimus-Eluting Bioresorbable Vascular Scaffold, strictly adhere to CDSCO guidelines and ISO 13485:2016 quality standards.
The MeRes100 BRS Sirolimus-Eluting Bioresorbable Vascular Scaffold is constructed using PLLA (Poly L-lactide), ensuring high biocompatibility and durability.
Coronary Stents
Coronary Stents
Coronary Stents
Coronary Stents